Our People

Tyra has built a nimble and experienced team to rapidly translate new discoveries into the clinic with a singular focus on acquired resistance in oncology.

Board Members

Bob More

Sid Subramony

Todd Harris

Gilla Kaplan

Nina Kjellson

Isan Chen

Jake Simson

Company

Robert L. Hudkins

Esther van den Boom

Lindy Schermerhorn

Dan Bensen

Todd Harris

Mike Riley

Ronald V. Swanson

Jane Arboleda

Piyush Patel

Scientific Advisors

Jeffrey Hager

William Hahn

Jason Sheltzer

Investors

venture-Alta

venture-RA-Capital

venture-Boxer-Capital

venture-Canaan